<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18711265</article-id><article-id pub-id-type="pmc">2636133</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_5_377_42413</article-id><article-categories><subj-group subj-group-type="heading"><subject>Symposium</subject></subj-group></article-categories><title-group><article-title>Posterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Banker</surname><given-names>Alay S</given-names></name><degrees>MS</degrees></contrib></contrib-group><aff>Banker&#x02032;s Retina Clinic and Laser Centre, 5 Subhash Society, BehindIshvar Bhuvan, Ahmedabad 380 009, India</aff><author-notes><corresp id="cor1">Correspondence to Dr. Alay S. Banker, Banker?s Retina Clinic andLaser Centre, 5 Subhash Society, Behind Ishvar Bhuvan, Ahmedabad -380 009, India. Email: <email>alay.banker@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2008</year></pub-date><volume>56</volume><issue>5</issue><fpage>377</fpage><lpage>383</lpage><history><date date-type="received"><day>08</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2008</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalwork is properly cited.</license-p></license></permissions><abstract><p>Ocular manifestations can occur in up to 50% of human immunodeficiency virus (HIV)/acquired immunedeficiency syndrome (AIDS) patients and posterior segment involvement is the most common presentation.The posterior segment manifestations of AIDS can be divided into four categories: retinal vasculopathy,opportunistic infections, unusual malignancies and neuro-ophthalmologic abnormalities. Retinalmicrovasculopathy and cytomegalovirus (CMV) retinitis are the most common manifestations, even in theera of highly active anti-retroviral therapy (HAART). Highly active anti-retroviral therapy has been shownto cause regression of CMV retinitis, reduce the incidence of CMV-related retinal detachments, and prolongpatient survival. Immune recovery uveitis is a new cause of vision loss in patients on HAART. Diagnosis andtreatment are guided by the particular conditions and immune status of the patient.</p></abstract><kwd-group><kwd>Acquired immune deficiency syndrome</kwd><kwd>cytomegalovirus retinitis</kwd><kwd>highly active antiretroviral therapy</kwd><kwd>immune recovery uveitis</kwd><kwd>microvasculopathy</kwd><kwd>posterior segment</kwd></kwd-group></article-meta></front><body><p>As per the United Nations acquired immune deficiencysyndrome (UNAIDS)/World Health organization (WHO)acquired immune deficiency syndrome (AIDS) epidemicupdate, December 2006, there are about 39.5 million (34.1-47.1million) people globally living with human immunodeficiencyvirus (HIV).<xref ref-type="bibr" rid="ref1">1</xref> Out of these, about 5.2-5.7 million people arefrom India.<xref ref-type="bibr" rid="ref2">2</xref> In spite of the widespread use of highly activeantiretroviral therapy (HAART) today, ocular manifestationsof AIDS at some point affect 50 to 75% of infected persons, ofwhich posterior segment involvement is the most common.<xref ref-type="bibr" rid="ref3">3</xref>Also, the spectrum of ocular manifestations of AIDS in thedeveloping world differs from that of developed nations.<xref ref-type="bibr" rid="ref4">4</xref>The purpose of this article is to review all posterior segmentmanifestations of AIDS. The posterior segment manifestationsin AIDS patients can be divided into four main categories:vasculopathy, opportunistic infections, unusual malignanciesand neuro-ophthalmologic abnormalities.</p><sec><title>Vasculopathy</title><p>Microvasculopathy is the most common ocular manifestationof AIDS, seen in about 40% to 60% of HIV-positive patients.<xref ref-type="bibr" rid="ref5">5</xref>Clinically, it manifests as cotton-wool spots located inthe posterior pole and may simulate small patches ofcytomegalovirus (CMV) retinitis [<xref ref-type="fig" rid="F1">Figure 1</xref>]. However, unlikeCMV retinitis, cotton-wool spots are not associated withlarge amounts of hemorrhages, subtle iritis, or mild posteriorvitritis. They have more rounded borders, and are usuallyoriented along the vascular arcades, and represent focalareas of ischemia in the nerve fiber layer. Most patients withretinal microvasculopathy are asymptomatic. Treatment is notindicated in most cases. The prevalence of microvasculopathyis inversely proportional to CD4+ count.</p></sec><sec><title>Large vessel disease</title><p>Large vessel occlusions, including central and branch retinalvein occlusions and branch retinal artery occlusions areuncommon and usually occur in association with viral retinitis,infiltrative lymphomatous optic neuropathy, and as isolatedabnormalities.<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref8">8</xref> Frosted branch vasculitis has beenassociated with CMV retinitis in AIDS.<xref ref-type="bibr" rid="ref9">9</xref></p></sec><sec sec-type=""><title>Posterior segment opportunistic infections</title><p>Ocular posterior segment opportunistic infections aremanifestations of disseminated disease in AIDS patients andare recognized either as necrotizing retinitis or as unifocalor multifocal choroiditis. Retinitis is more common thanchoroiditis. Retinitis in quiet eyes occurs in patients withlower CD4+ counts and is more commonly due to CMV andprogressive outer retinal necrosis (PORN), while retinitisin inflamed eyes usually occur in patients with higherCD4+ counts and is more commonly due to acute retinalnecrosis (ARN), toxoplasmosis, syphilis, or late stages ofcryptococcus.</p><sec><title>Cytomegalovirus retinitis</title><p>Cytomegalovirus retinitis is the most common AIDS-relatedocular opportunistic infection and can develop in up to 40 to50% of AIDS patients prior to HAART.<xref ref-type="bibr" rid="ref5">5</xref> Although its incidencehas declined markedly since the advent of HAART in thewestern world, it still remains the leading cause of ocularmorbidity in the developing countries.<xref ref-type="bibr" rid="ref10">10</xref> In India, CMVretinitis still remains the commonest ocular manifestationin AIDS cases.<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref> In our series of 1286 cases, theincidence of CMV retinitis remains high even in the era of HAART[<xref ref-type="table" rid="T1">Table 1</xref>]. It may be unilateral to start with, but up to 52%will eventually develop bilateral disease. Cytomegalovirusretinitis occurs almost exclusively in patients whoseCD4+ counts are &#x0003c;50 cells/&#x000b5;l.<xref ref-type="bibr" rid="ref13">13</xref> However, its diagnosis cannotbe excluded based on CD4+ count alone in patients takingHAART. In exceptionally rare instances, CMV retinitis maydevelop in patients with elevated CD4+ counts shortly afterthe initiation of HAART.</p><p><italic><bold>Clinical findings</bold></italic>: There are three clinical forms of CMVretinitis. The classical form (pizza pie retinopathy or cottagecheese with ketchup) is characterized by confluent retinalnecrosis with hemorrhage that develops mostly in the posteriorretina [<xref ref-type="fig" rid="F2A">Figure 2A</xref>]. The advancing edge of these lesions isusually very sharp and spreads contiguously. Typically, overseveral weeks untreated lesions progress to full-thicknessnecrosis with resultant retinal gliosis and pigment epithelialatrophy. Patients often have loss of visual field or visual acuityand scotoma. In contrast, the indolent form is recognized asa granular lesion in the peripheral retina, often with little orno hemorrhage [<xref ref-type="fig" rid="F2B">Figure 2B</xref>]. Patients may notice floaters, orthey may be asymptomatic. A third uncommon presentationis frosted branch angiitis [<xref ref-type="fig" rid="F2C">Figure 2C</xref>]. Because approximately15% of patients with active CMV retinitis are asymptomatic,routine screening with dilated indirect ophthalmoscopyhas been recommended at three-month intervals in patientswith CD4+ counts less than 50 cells/&#x000b5;l.<xref ref-type="bibr" rid="ref14">14</xref> Cytomegalovirusretinitis may result in either serous or rhegmatogenous retinaldetachment, although the latter is much more common.Rhegmatogenous retinal detachment has been reported in 13to 29% of patients with CMV retinitis and may occur during theactive or healed phase of the disease. However, since the adventof HAART, incidence of retinal detachment has decreased byapproximately 60 to 77% in the western world.<xref ref-type="bibr" rid="ref15">15</xref> In contrast,in our series, the incidence of CMV-related retinal detachmentwas found to have increased [<xref ref-type="table" rid="T1">Table 1</xref>]. This may be due tohigher number of patients taking inappropriate HAART, orpeople taking HAART have larger areas of healed CMV retinitiswhich eventually develop necrotic holes leading to detachment.Various approaches including pars plana vitrectomy (PPV)with gas or silicone oil tamponade (preferably high viscosity5000CS), scleral buckling and laser demarcation have beeneffective in the repair of retinal detachments related to CMVretinitis.<xref ref-type="bibr" rid="ref16">16</xref></p><p><italic><bold>Treatment</bold></italic>: Treatment of CMV retinitis is individualizedand depends upon the location of the active retinitis and theimmune status of the patient. Currently available anti-CMVagents include ganciclovir and its prodrug valganciclovir,foscarnet, cidofovir, fomivirsen, ganciclovir implant and oralvalganciclovir. A brief summary of these drugs is providedin <xref ref-type="table" rid="T2">Table 2</xref>.</p></sec><sec><title>Necrotizing herpetic retinopathy</title><p>Necrotizing herpetic retinopathy (NHR) is a continuousspectrum of posterior segment inflammation induced byherpes viruses, most commonly varicella zoster virus (VZV).Its two most recognizable clinical patterns are ARN [<xref ref-type="fig" rid="F3">Figure 3</xref>]and PORN [<xref ref-type="fig" rid="F4">Figure 4</xref>]. Usually, the former occurs in healthypersons and AIDS patients with only mild immune dysfunctionand elevated CD4+ counts, whereas the latter usually developsin those who are severely immunosuppressed.<xref ref-type="bibr" rid="ref17">17</xref> In additionto varicella zoster virus, herpes simplex virus and CMV havebeen isolated in patients with ARN, and herpes simplex ineyes with PORN.<xref ref-type="bibr" rid="ref18">18</xref> The differential features between ARN,PORN and CMV retinitis are given in <xref ref-type="table" rid="T3">Table 3</xref>.</p><p>Aggressive medical treatment with appropriate systemicantivirals may improve long-term visual outcome in patientswith NHR. Treatment of ARN includes intravenous acyclovir(1500 mg/sq, meter/day in three divided doses) for seven to10 days followed by oral acyclovir (800 mg five times daily) forsix weeks.<xref ref-type="bibr" rid="ref12">12</xref> Following resolution of retinitis, prophylactic laserbarrage is considered beneficial to prevent retinal detachment.However, visual loss due to progressive infection, optic nervesheath effusion, or, in most cases, retinal detachment occursin up to 70 to 85% of patients. Retinal detachment requiresvitrectomy, intravitreal silicone oil tamponade and endolaserphotocoagulation.</p></sec><sec><title>Toxoplasmosis</title><p>In the majority of AIDS cases, toxoplasmosis is a primaryinfection rather than a reactivation. Ocular toxoplasmosisin AIDS, in contrast to toxoplasmosis in immunocompetentindividuals, is often bilateral, multifocal, and not associatedwith chorioretinal scars. It may cause a variety of ocularabnormalities including iritis, vitritis, choroiditis, multifocal ordiffuse necrotizing retinitis [<xref ref-type="fig" rid="F5">Figure 5</xref>], papillitis or retrobulbarneuritis, or outer retinal toxoplasmosis.<xref ref-type="bibr" rid="ref19">19</xref> Toxoplasmaretinitis may resemble CMV retinitis; however, intraocularinflammation is usually more severe and hemorrhagesare fewer. Treatment with standard antiparasitic drugs(pyrimethamine, clindamycin, sulfonamides) is successful incontrolling ocular toxoplasmosis in most cases.</p></sec><sec><title>Choroiditis</title><sec><title>Pneumocystis</title><p>Ocular manifestations of <italic> P. carinii</italic> include conjunctivitis, orbitalmass, optic neuropathy, and choroiditis.<xref ref-type="bibr" rid="ref20">20</xref> It is seen as classicallybilateral and multifocal yellowish, well-demarcated, choroidallesions located in the posterior pole not associated with vitritis,iritis, or vasculitis [<xref ref-type="fig" rid="F6">Figure 6</xref>].<xref ref-type="bibr" rid="ref21">21</xref> Ocular lesionsrespond in most cases to induction and subsequent maintenance treatment withsystemic pentamidine, trimethoprim and sulfamethoxazole,or dapsone.</p></sec><sec><title>Cryptococcus</title><p>Cryptococcus meningitis is the most common cause of AIDS-related neuro-ophthalmolgic lesions. Cryptococcal choroiditismay be multifocal, solitary, or confluent and may be associatedwith eyelid nodule, conjunctival mass, granulomatous iritis,iris mass, vitritis, necrotizing retinitis, endophthalmitis, andoptic neuritis [<xref ref-type="fig" rid="F7">Figure 7</xref>].<xref ref-type="bibr" rid="ref22">22</xref> Fluconazole maintenancetherapy 200 mg/day is currently recommended in all patients even inthe era of HAART.</p></sec></sec></sec><sec sec-type=""><title>Ocular tuberculosis</title><p>Though pulmonary tuberculosis is the commonest systemicopportunistic infection seen in AIDS cases in India, the incidenceof ocular tuberculosis is very low. In our study of 1286 cases,we found only 1% cases with presumed ocular tuberculosis.It usually presents as multifocal choroidal tubercles withdiscrete yellow lesions mainly at the posterior pole [<xref ref-type="fig" rid="F8">Figure 8</xref>].It may be associated with an exudative retinal detachmentwith variable vitreous inflammation. Occasionally, however,it may present as a big solitary posterior pole granuloma-likemass lesion [<xref ref-type="fig" rid="F9">Figure 9</xref>].<xref ref-type="bibr" rid="ref23">23</xref> Treatment with long-termsystemic anti-tuberculous drugs is effective in most cases. The spectrumof ocular tuberculosis, however, is changing in today&#x02032;s era ofHAART. Recently, there has been a report of worsening of oculartuberculosis in HIV patients after antiretroviral therapy.<xref ref-type="bibr" rid="ref24">24</xref></p></sec><sec sec-type=""><title>Unusual malignancies</title><p>Reported posterior segment manifestations of non-Hodgkin&#x02032;slymphoma (NHL) include necrotizing retinitis, multifocalchoroiditis, retinal vasculitis, vitritis, subretinal mass, andpseudo-hypopyon uveitis.<xref ref-type="bibr" rid="ref25">25</xref> Treatment options includeradiation and chemotherapy.</p></sec><sec sec-type=""><title>Neuro-ophthalmologic abnormalities</title><p>Neuro-ophthalmologic abnormalities usually are an indicationof infection or lymphoma of the brain or meninges and occurin only 6% of AIDS patients. Clinical abnormalities of theoptic nerve in a patient with AIDS may be recognized asperineuritis, papilledema, papillitis, retrobulbar neuritis, andoptic atrophy.<xref ref-type="bibr" rid="ref26">26</xref></p></sec><sec sec-type=""><title>Syphilis</title><p>Ocular syphilis in AIDS may present as iritis, vitritis,retrobulbar optic neuritis, perineuritis, papillitis, neuroretinitis,retinal vasculitis, a necrotizing retinitis which may beclinically indistinguishable from CMV and exudative retinaldetachment.<xref ref-type="bibr" rid="ref27">27</xref> Syphilis in AIDS may develop when CD4+counts are greater than 200 cells/&#x000b5;l and, consequently, syphilis,including ocular syphilis, may be the presenting illness leadingto the diagnosis of AIDS. It has been recommended that 12 to24 million units of intravenous aqueous penicillin beadministered for 10 days in AIDS patients with ocularsyphilis.</p></sec><sec sec-type=""><title>Ocular manifestations of HIV in the era ofHAART</title><p>The advent of potent antiretroviral therapy has had a profoundimpact on the ophthalmological manifestations of AIDSpatients. As these drugs lead to improved immune function,patients have fewer opportunistic infections. There havebeen reports of dramatic decreases in the frequency of CMVretinitis in areas where three- and four-drug antiretroviralcombination therapies are routinely being used. In addition todecreased incidence, there are improved outcomes in patientswith CMV retinitis who received new active antiretroviraltherapy in addition to anti-CMV therapy.<xref ref-type="bibr" rid="ref28">28</xref> In many patientswith healed CMV retinitis who have responded to HAART,anti-CMV therapy has been discontinued without reactivationof the retinitis. In our study where combination antiretroviraltreatment was given to 12 patients with active CMV retinitis,all anti-CMV cellcounts were &#x0003e;100/mm<sup>3</sup> for three months.<xref ref-type="bibr" rid="ref29">29</xref> The median CD4cell count increased from 36.5/mm<sup>3</sup> (range, 3 to 74/mm<sup>3</sup>) atbaseline to 175.5/mm3 (range, 97 to 410/mm<sup>3</sup>) at three months.No patient had reactivation of CMV retinitis or developmentof extraocular CMV during median follow-up of 16.7 months.Although at present there are no standardized criteria fordetermining whether immunologic improvement is sufficientto allow withdrawal of therapy, a CD4+ cell count of at least100 cells/mcL for at least three to six months, or a rise of atleast 50 cells/mcL has been recommended.<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref>Reactivation of CMV retinitis has been reported in patients who discontinueor become intolerant to HAART. When maintenance therapyis discontinued, close observation is required.</p><sec><title>Immune recovery uveitis</title><p>Immune recovery uveitis (IRU) is a noninfectious intraocularinflammation which develops in patients with inactive CMVretinitis who have had a substantial elevation in CD4+ countwith HAART. Immune recovery uveitis is the leading causeof new visual loss in persons with AIDS seen in about 16 to63% of HAART responders. The severity of the inflammationdepends on the degree of immune reconstitution, extentof CMV retinitis, amount of intraocular CMV antigen,and previous treatment. Clinical findings include anteriorchamber or vitreous reaction [<xref ref-type="fig" rid="F10">Figure 10</xref>], panuveitis withhypopon, optic disk and cystoid macular edema, epiretinalmembrane formation, cataract, vitreomacular tractionsyndrome, and proliferative vitreoretinopathy.<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref>Treatment with corticosteroids (subtenon or systemic or intravitreal) iseffective in controlling inflammation and improving visionin some cases. However, surgery may be required in patientswith vitreomacular traction syndrome, epiretinal membraneformation, cataract, and proliferative vitreoretinopathy.</p></sec></sec><sec sec-type=""><title>Summary</title><p>CMV retinitis is much less common in the era of HAART butremains one of the commonest ocular complications of AIDSin India. Highly active anti-retroviral therapy has been shownto cause regression of opportunistic infections, including CMVretinitis, increase time to relapse of CMV retinitis, reduce theincidence of CMV-related retinal detachments, and prolongpatient survival. Patients with inactive CMV retinitis whohave responded to HAART with a CD4+ cell count &#x0003e;100 cells/mcL for more than three to six months may be candidatesfor discontinuation of CMV maintenance therapy. Closefollow-up for any signs of reactivation is mandatory. Immunerecovery uveitis has been reported in patients with healedCMV retinitis who have responded to HAART. Necrotizingherpetic retinopathy and ocular tuberculosis are other commonposterior segment disorders seen in AIDS cases.</p></sec></body><back><fn-group><fn><p>Source of Support: Nil</p></fn><fn><p>Conflict of Interest: None declared</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="webpage"><source>UNAIDS, AIDS epidemic update: Special report on HIV/AIDS:December 2006</source><date-in-citation>last accessed on 2007 Oct 31</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf">http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdateen.pdf</ext-link></comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="webpage"><source>National AIDS Control Organization, Ministry of Health andfamily affairs, Government of India. HIV/AIDS epidemiologicalSurveillance and Estimation report for the year 2005</source><year>2006</year><date-in-citation>last accessed on 2007 Oct 31</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nacoonline.org/fnlapil06rprt.pdf">http://www.nacoonline.org/fnlapil06rprt.pdf</ext-link></comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kestelyn</surname><given-names>PG</given-names></name><name><surname>Cunningham Jr</surname><given-names>ET</given-names></name></person-group><article-title>HIV/AIDS and blindness</article-title><year>2001</year><volume>79</volume><fpage>208</fpage><lpage>13</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrabec</surname><given-names>TR</given-names></name></person-group><article-title>Posterior segment manifestations of HIV-AIDS</article-title><source>Surv Ophthalmol</source><year>2004</year><volume>49</volume><fpage>131</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">14998690</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabs</surname><given-names>DA</given-names></name></person-group><article-title>Ocular manifestations of HIV infection</article-title><source>Trans Am Ophthalmol Soc</source><year>1995</year><volume>93</volume><fpage>623</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8719695</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>MD</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Olk</surname><given-names>RJ</given-names></name></person-group><article-title>Branch retinal artery occlusion(BRAO) combined with branch retinal vein occlusion (BRVO)and optic disc neovascularization associated with HIV and CMVretinitis</article-title><source>Int Ophthalmol</source><year>1996</year><volume>19</volume><fpage>249</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">8737706</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>SM</given-names></name><name><surname>Margo</surname><given-names>CE</given-names></name></person-group><article-title>Bilateral central retinal vein occlusionsin a patient with acquired immunodeficiency syndrome: Clinico-pathologic correlations</article-title><source>Arch Ophthalmol</source><year>1995</year><volume>113</volume><fpage>1184</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7661754</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KL</given-names></name><name><surname>Marx</surname><given-names>JL</given-names></name><name><surname>Lopez</surname><given-names>PF</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name></person-group><article-title>Noninfectious branch retinalvein occlusion in HIV-positive patients</article-title><source>Retina</source><year>1997</year><volume>17</volume><fpage>162</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9143047</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>HK</given-names></name></person-group><article-title>Frosted retinal periphlebitis in the acquiredimmunodeficiency syndrome</article-title><source>Ophthalmologica</source><year>1993</year><volume>207</volume><fpage>182</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8115111</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holbrook</surname><given-names>JT</given-names></name><name><surname>Jabs</surname><given-names>DA</given-names></name><name><surname>Weinberg</surname><given-names>DV</given-names></name><name><surname>Lewis</surname><given-names>RA</given-names></name><name><surname>Davis</surname><given-names>MD</given-names></name><name><surname>Friedberg</surname><given-names>D</given-names></name><etal/></person-group><article-title>Visual loss in patients with cytomegalovirusretinitis and acquired immunodeficiency syndrome beforewidespread availability of highly active antiretiroviral therapy</article-title><source>Arch Ophthalmol</source><year>2003</year><volume>121</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">12523893</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Madhavan</surname><given-names>HN</given-names></name><name><surname>George</surname><given-names>AE</given-names></name><name><surname>Kumarasamy</surname><given-names>N</given-names></name><name><surname>Solomon</surname><given-names>S</given-names></name></person-group><article-title>Ocular lesions associated with HIV infection in India: A seriesof 100 consecutive patients evaluated at a referral center</article-title><source>Am J Ophthalmol</source><year>2000</year><volume>129</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10653406</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Fogla</surname><given-names>R</given-names></name><name><surname>Gopal</surname><given-names>L</given-names></name><name><surname>Narayana</surname><given-names>KM</given-names></name><name><surname>Banker</surname><given-names>AS</given-names></name><name><surname>Kumarsamy</surname><given-names>N</given-names></name><etal/></person-group><article-title>Current approaches to diagnosis and management of ocularlesions in human immunodeficiency virus positive patients</article-title><source>Indian J Ophthalmol</source><year>2002</year><volume>50</volume><fpage>83</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">12194584</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuppermann</surname><given-names>BD</given-names></name><name><surname>Petty</surname><given-names>JG</given-names></name><name><surname>Richman</surname><given-names>DD</given-names></name><name><surname>Mathews</surname><given-names>WC</given-names></name><name><surname>Fullerton</surname><given-names>SC</given-names></name><name><surname>Rickman</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Correlation between CD4+counts and prevalence of cytomegalovirus retinitis and humanimmunodeficiency virus-related noninfectious retinal vasculopathyin patients with acquired immunodeficiency syndrome</article-title><source>Am J Ophthalmol</source><year>1993</year><volume>115</volume><fpage>575</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">8098183</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldassano</surname><given-names>VF</given-names></name><name><surname>Dunn</surname><given-names>JP</given-names></name><name><surname>Feinberg</surname><given-names>J</given-names></name><name><surname>Jabs</surname><given-names>DA</given-names></name></person-group><article-title>Cytomegalovirusretinitis and low CD4+ T-lymphocyte counts</article-title><source>N Engl J Med</source><year>1995</year><volume>333</volume><fpage>670</fpage><pub-id pub-id-type="pmid">7637742</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassoux</surname><given-names>N</given-names></name><name><surname>Bodaghi</surname><given-names>B</given-names></name><name><surname>Lautier-Frau</surname><given-names>M</given-names></name><name><surname>Fardeau</surname><given-names>C</given-names></name><name><surname>lehoang</surname><given-names>P</given-names></name></person-group><article-title>Current status of retinal detachment in AIDS patients</article-title><source>J Fr Ophtalmol</source><year>2000</year><volume>23</volume><fpage>1031</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">11139700</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>WR</given-names></name><name><surname>Quiceno</surname><given-names>JI</given-names></name><name><surname>Crapotta</surname><given-names>JA</given-names></name><name><surname>Listhaus</surname><given-names>A</given-names></name><name><surname>Munguia</surname><given-names>D</given-names></name><name><surname>Aguilar</surname><given-names>MF</given-names></name></person-group><article-title>Surgical repair of rhegmatogenous retinal detachmentin immunosuppressed patients with cytomegalovirus retinitis</article-title><source>Ophthalmology</source><year>1992</year><volume>99</volume><fpage>466</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">1314364</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guex-Crosier</surname><given-names>Y</given-names></name><name><surname>Rochat</surname><given-names>C</given-names></name><name><surname>Herbort</surname><given-names>CP</given-names></name></person-group><article-title>Necrotizing herpeticretinopathies: A spectrum of herpes virus-induced diseasesdetermined by the immune state of the host</article-title><source>Ocul Immunol Inflamm</source><year>1997</year><volume>5</volume><fpage>259</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">9455742</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ormerod</surname><given-names>LD</given-names></name><name><surname>Larkin</surname><given-names>JA</given-names></name><name><surname>Margo</surname><given-names>CA</given-names></name><name><surname>Pava</surname><given-names>PR</given-names></name><name><surname>Menosky</surname><given-names>NM</given-names></name><name><surname>Haight</surname><given-names>DO</given-names></name><etal/></person-group><article-title>Rapidly progressive herpetic retinal necrosis: Ablinding disease characteristic of advanced AIDS</article-title><source>Clin Infect Dis</source><year>1998</year><volume>26</volume><fpage>34</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">9455507</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>GN</given-names></name><name><surname>Engstrom</surname><given-names>RE</given-names><suffix>Jr</suffix></name><name><surname>Glasgow</surname><given-names>BJ</given-names></name><name><surname>Berger</surname><given-names>BB</given-names></name><name><surname>Daniels</surname><given-names>SA</given-names></name><name><surname>Sidikaro</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Ocular toxoplasmosis in patients with the acquiredimmunodeficiency syndrome</article-title><source>Am J Ophthalmol</source><year>1988</year><volume>106</volume><fpage>653</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">3195645</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>WR</given-names></name><name><surname>Gross</surname><given-names>JG</given-names></name><name><surname>Labelle</surname><given-names>J</given-names></name><name><surname>Oteken</surname><given-names>K</given-names></name><name><surname>Katz</surname><given-names>B</given-names></name><name><surname>Wiley</surname><given-names>CA</given-names></name></person-group><article-title><italic>Pneumocystis carinii</italic> choroidopathy: A new clinical entity</article-title><source>Arch Ophthalmol</source><year>1989</year><volume>107</volume><fpage>863</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2786409</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shami</surname><given-names>MJ</given-names></name><name><surname>Freeman</surname><given-names>W</given-names></name><name><surname>Friedberg</surname><given-names>D</given-names></name><name><surname>Siderides</surname><given-names>E</given-names></name><name><surname>Listhaus</surname><given-names>A</given-names></name><name><surname>Ai</surname><given-names>E</given-names></name></person-group><article-title>A multicenter study of pneumocystis choroidopathy</article-title><source>Am J Ophthalmol</source><year>1991</year><volume>112</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">1882916</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muccioli</surname><given-names>C</given-names></name><name><surname>Belfort</surname><given-names>R</given-names></name><name><surname>Neves</surname><given-names>R</given-names></name><name><surname>Rao</surname><given-names>N</given-names></name></person-group><article-title>Limbal and choroidalCryptococcus infection in the acquired immunodeficiencysyndrome</article-title><source>Am J Ophthalmol</source><year>1995</year><volume>120</volume><fpage>539</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">7573321</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>RB</given-names></name><name><surname>Sudharshan</surname><given-names>S</given-names></name><name><surname>Kumarasamy</surname><given-names>N</given-names></name><name><surname>Therese</surname><given-names>L</given-names></name><name><surname>Biswas</surname><given-names>J</given-names></name></person-group><article-title>Ocular tuberculosis in acquired immunodeficiency syndrome</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>142</volume><fpage>413</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16935585</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name><name><surname>Lalitha</surname><given-names>P</given-names></name></person-group><article-title>Paradoxical worsening of oculartuberculosis in HIV patients after antiretroviral therapy</article-title><source>Eye</source><year>2007</year><volume>21</volume><fpage>667</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17139273</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivero</surname><given-names>ME</given-names></name><name><surname>Kuppermann</surname><given-names>BD</given-names></name><name><surname>Wiley</surname><given-names>CA</given-names></name><name><surname>Garcia</surname><given-names>CR</given-names></name><name><surname>Smith</surname><given-names>MD</given-names></name><name><surname>Dreilinger</surname><given-names>A</given-names></name><etal/></person-group><article-title>Acquired immunodeficiency syndrome-relatedintraocular B-cell lymphoma</article-title><source>Arch Ophthalmol</source><year>1999</year><volume>117</volume><fpage>616</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10326958</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>AM</given-names></name></person-group><article-title>Neuro-ophthalmic findings in acquiredimmunodeficiency syndrome</article-title><source>J Clin Neuroophthalmol</source><year>1990</year><volume>10</volume><fpage>167</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">2168900</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeish</surname><given-names>WM</given-names></name><name><surname>Pulido</surname><given-names>JS</given-names></name><name><surname>Holland</surname><given-names>S</given-names></name><name><surname>Culbertson</surname><given-names>WW</given-names></name><name><surname>Winward</surname><given-names>K</given-names></name></person-group><article-title>Theocular manifestations of syphilis in the human immunodeficiencyvirus type 1-infected host</article-title><source>Ophthalmology</source><year>1990</year><volume>97</volume><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">2326008</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>JB</given-names></name><name><surname>Schwab</surname><given-names>IR</given-names></name><name><surname>Gordon</surname><given-names>J</given-names></name><name><surname>Morse</surname><given-names>LS</given-names></name></person-group><article-title>Regression of cytomegalovirusretinitis associated with protease-inhibitor treatment in patients withAIDS</article-title><source>Am J Ophthalmol</source><year>1997</year><volume>124</volume><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">9262543</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banker</surname><given-names>AS</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name></person-group><article-title>Effect of combination antiretroviral therapyon cytomegalovirus retinitis</article-title><source>Indian J Opthalmol</source><year>2002</year><volume>50</volume><fpage>29</fpage><lpage>33</lpage></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrabec</surname><given-names>TR</given-names></name><name><surname>Baldassano</surname><given-names>VF</given-names></name><name><surname>Whitcup</surname><given-names>SM</given-names></name></person-group><article-title>Discontinuation ofmaintenance therapy in patients with quiescent cytomegalovirusretinitis and elevated CD4+ counts</article-title><source>Ophthalmology</source><year>1998</year><volume>105</volume><fpage>1259</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">9663231</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tural</surname><given-names>C</given-names></name><name><surname>Romeu</surname><given-names>J</given-names></name><name><surname>Sirera</surname><given-names>G</given-names></name><name><surname>Andreu</surname><given-names>D</given-names></name><name><surname>Conejero</surname><given-names>M</given-names></name><name><surname>Ruiz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Long-lasting remission of cytomegalovirus retinitis withoutmaintenance therapy in human immunodeficiency virus-infectedpatients</article-title><source>J Infect Dis</source><year>1998</year><volume>177</volume><fpage>1080</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">9534987</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karavellas</surname><given-names>MP</given-names></name><name><surname>Azen</surname><given-names>SP</given-names></name><name><surname>MacDonald</surname><given-names>JC</given-names></name><name><surname>Shufelt</surname><given-names>CL</given-names></name><name><surname>Lowder</surname><given-names>CY</given-names></name><name><surname>Plummer</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Immune recovery vitritis and uveitis in AIDS:Clinical predictors, sequelae and treatment outcomes</article-title><source>Retina</source><year>2001</year><volume>21</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11217922</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karavellas</surname><given-names>MP</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>McDonald</surname><given-names>JC</given-names></name><name><surname>Freeman</surname><given-names>WR</given-names></name></person-group><article-title>Longtermposterior and anterior segment complications of immune recoveryuveitis associated with cytomegalovirus retinitis</article-title><source>Am J Ophthalmol</source><year>2000</year><volume>130</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">11004260</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Microvasculopathy</p></caption><alt-text>Figure 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g001"/></fig><fig id="F2A" position="float"><label>Figure 2A</label><caption><p>(A) Classic CMV retinitis: pizza-pie appearance</p></caption><alt-text>Figure 2A</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g003"/></fig><fig id="F2B" position="float"><label>Figure 2B</label><caption><p>(B) Granular variety of CMV retinitis</p></caption><alt-text>Figure 2B</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g004"/></fig><fig id="F2C" position="float"><label>Figure 2C</label><caption><p>(C) Frosted-branch angiitis variety of CMV retinitis</p></caption><alt-text>Figure 2C</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g005"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Acute retinal necrosis</p></caption><alt-text>Figure 3</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g007"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Progressive outer retinal necrosis</p></caption><alt-text>Figure 4</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g008"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Toxoplasmic retinochoroiditis</p></caption><alt-text>Figure 5</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g010"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p>Pneumocystic choroiditis</p></caption><alt-text>Figure 6</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g011"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p>Cryptococcus involvement of optic nerve and retina</p></caption><alt-text>Figure 7</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g012"/></fig><fig id="F8" position="float"><label>Figure 8</label><caption><p>Multiple choroidal tubercles due to ocular tuberculosis</p></caption><alt-text>Figure 8</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g013"/></fig><fig id="F9" position="float"><label>Figure 9</label><caption><p>Solitary mass lesion due to ocular tuberculosis</p></caption><alt-text>Figure 9</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g014"/></fig><fig id="F10" position="float"><label>Figure 10</label><caption><p>Severe vitritis due to immune recovery uveitis</p></caption><alt-text>Figure 10</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g015"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Ocular manifestations in 1286 acquired immunodeficiency syndrome cases</p></caption><alt-text>Table 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g002"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Medications for cytomegalovirus retinitis</p></caption><alt-text>Table 2</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g006"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Differentiating features of three types of viral retinitis in acquired immunodeficiency syndrome</p></caption><alt-text>Table 3</alt-text><graphic xlink:href="IndianJOphthalmol-56-377-g009"/></table-wrap></floats-group></article>